Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
Front Immunol. 2018 Jun 8;9:1247. doi: 10.3389/fimmu.2018.01247. eCollection 2018.
Monocytes are able to undergo homotypic fusion to produce different types of multinucleated giant cells, such as Langhans giant cells in response to infection or foreign body giant cells in response to implanted biomaterials. Monocyte fusion is highly coordinated and complex, with various soluble, intracellular, and cell-surface components mediating different stages of the process. Tetraspanins, such as CD9, CD63, and CD81, are known to be involved in cell:cell fusion and have been suggested to play a role in regulating homotypic monocyte fusion. However, peripheral human monocytes are not homogenous: they exist as a heterogeneous population consisting of three subsets, classical (CD14CD16), intermediate (CD14CD16), and non-classical (CD14CD16), at steady state. During infection with mycobacteria, the circulating populations of intermediate and non-classical monocytes increase, suggesting they may play a role in the disease outcome. Human monocytes were separated into subsets and then induced to fuse using concanavalin A. The intermediate monocytes were able to fuse faster and form significantly larger giant cells than the other subsets. When antibodies targeting tetraspanins were added, the intermediate monocytes responded to anti-CD63 by forming smaller giant cells, suggesting an involvement of tetraspanins in fusion for at least this subset. However, the expression of fusion-associated tetraspanins on monocyte subsets did not correlate with the extent of fusion or with the inhibition by tetraspanin antibody. We also identified a CD9 and a CD9 monocyte population within the classical subset. The CD9 classical monocytes expressed higher levels of tetraspanin CD151 compared to CD9 classical monocytes but the CD9 classical subset did not exhibit greater potential to fuse and the role of these cells in immunity remains unknown. With the exception of dendrocyte-expressed seven transmembrane protein, which was expressed at higher levels on the intermediate monocyte subset, the expression of fusion-related proteins between the subsets did not clearly correlate with their ability to fuse. We also did not observe any clear correlation between giant cell formation and the expression of pro-inflammatory or fusogenic cytokines. Although tetraspanin expression appears to be important for the fusion of intermediate monocytes, the control of multinucleate giant cell formation remains obscure.
单核细胞能够发生同质融合,以产生不同类型的多核巨细胞,例如 Langhans 巨细胞(对感染的反应)或异物巨细胞(对植入生物材料的反应)。单核细胞融合高度协调和复杂,各种可溶性、细胞内和细胞表面成分介导该过程的不同阶段。四跨膜蛋白,如 CD9、CD63 和 CD81,已知参与细胞间融合,并被认为在调节同源单核细胞融合中发挥作用。然而,外周血单核细胞不是同质的:它们作为一个异质群体存在,由三个亚群组成,经典(CD14CD16)、中间(CD14CD16)和非经典(CD14CD16),在稳态下。在分枝杆菌感染期间,中间和非经典单核细胞的循环群体增加,表明它们可能在疾病结局中发挥作用。人类单核细胞被分离成亚群,然后用刀豆蛋白 A 诱导融合。中间单核细胞能够更快地融合,并形成明显更大的巨细胞,比其他亚群。当针对四跨膜蛋白的抗体被加入时,中间单核细胞通过形成较小的巨细胞对抗-CD63 做出反应,这表明四跨膜蛋白至少在这个亚群的融合中起作用。然而,单核细胞亚群上融合相关四跨膜蛋白的表达与融合程度或四跨膜蛋白抗体的抑制无关。我们还在经典亚群内鉴定出 CD9 和 CD9 单核细胞群体。与 CD9 经典单核细胞相比,CD9 经典单核细胞表达更高水平的四跨膜蛋白 CD151,但 CD9 经典亚群没有表现出更大的融合潜力,这些细胞在免疫中的作用仍然未知。除了树突状细胞表达的七跨膜蛋白外,该蛋白在中间单核细胞亚群中的表达水平更高,融合相关蛋白在亚群之间的表达与它们融合的能力之间没有明显的相关性。我们也没有观察到巨细胞形成与促炎或融合原细胞因子的表达之间有任何明显的相关性。虽然四跨膜蛋白的表达似乎对中间单核细胞的融合很重要,但多核巨细胞形成的控制仍然不清楚。